Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $226.96 | 11 | 87.7% |
| Education | $31.80 | 1 | 12.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| PFIZER INC. | $74.56 | 2 | $0 (2021) |
| Merck Sharp & Dohme LLC | $48.42 | 3 | $0 (2023) |
| Tempus AI, Inc | $48.14 | 2 | $0 (2024) |
| Gilead Sciences, Inc. | $29.07 | 2 | $0 (2024) |
| Foundation Medicine, Inc. | $23.74 | 1 | $0 (2022) |
| Celgene Corporation | $18.49 | 1 | $0 (2023) |
| GlaxoSmithKline, LLC. | $16.34 | 1 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $64.13 | 3 | Tempus AI, Inc ($48.14) |
| 2023 | $79.99 | 5 | Merck Sharp & Dohme LLC ($48.42) |
| 2022 | $23.74 | 1 | Foundation Medicine, Inc. ($23.74) |
| 2021 | $48.14 | 2 | PFIZER INC. ($31.80) |
| 2019 | $42.76 | 1 | PFIZER INC. ($42.76) |
All Payment Transactions
12 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 07/18/2024 | Tempus AI, Inc | — | Food and Beverage | In-kind items and services | $24.27 | General |
| 03/21/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $15.99 | General |
| 02/22/2024 | Tempus AI, Inc | — | Food and Beverage | In-kind items and services | $23.87 | General |
| 08/31/2023 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological), LYNPARZA | Food and Beverage | In-kind items and services | $14.21 | General |
| Category: ONCOLOGY | ||||||
| 07/28/2023 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $13.08 | General |
| 06/29/2023 | Celgene Corporation | Pomalyst (Drug) | Food and Beverage | Cash or cash equivalent | $18.49 | General |
| Category: Hematology | ||||||
| 06/22/2023 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $18.43 | General |
| Category: ONCOLOGY | ||||||
| 04/13/2023 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological), LYNPARZA | Food and Beverage | In-kind items and services | $15.78 | General |
| Category: ONCOLOGY | ||||||
| 11/09/2022 | Foundation Medicine, Inc. | FOUNDATIONONE (Device), FOUNDATIONONE HEME, FOUNDATIONONE CDX | Food and Beverage | In-kind items and services | $23.74 | General |
| Category: ONCOLOGY | ||||||
| 12/07/2021 | GlaxoSmithKline, LLC. | BLENREP (Biological) | Food and Beverage | In-kind items and services | $16.34 | General |
| Category: ONCOLOGY | ||||||
| 08/13/2021 | PFIZER INC. | IBRANCE (Drug) | Education | In-kind items and services | $31.80 | General |
| Category: ONCOLOGY | ||||||
| 06/13/2019 | PFIZER INC. | PREVNAR - 13 (Biological) | Food and Beverage | In-kind items and services | $42.76 | General |
| Category: VACCINES | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 2 | 48 | 72 | $17,163 | $3,702 |
| 2022 | 3 | 66 | 103 | $24,838 | $5,721 |
| 2021 | 3 | 63 | 120 | $30,819 | $9,128 |
| 2020 | 2 | 58 | 107 | $34,449 | $7,996 |
All Medicare Procedures & Services
10 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 28 | 45 | $12,195 | $2,635 | 21.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 20 | 27 | $4,968 | $1,067 | 21.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 30 | 62 | $16,802 | $4,322 | 25.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2022 | 24 | 29 | $5,336 | $1,237 | 23.2% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Facility | 2022 | 12 | 12 | $2,700 | $161.72 | 6.0% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 35 | 87 | $23,577 | $6,995 | 29.7% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 12 | 15 | $3,930 | $1,253 | 31.9% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Facility | 2021 | 16 | 18 | $3,312 | $879.84 | 26.6% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Facility | 2020 | 26 | 58 | $21,170 | $5,138 | 24.3% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Facility | 2020 | 32 | 49 | $13,279 | $2,858 | 21.5% |
About Dr. Myra Rose, MD
Dr. Myra Rose, MD is a Hematology & Oncology healthcare provider based in Atlanta, Georgia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/21/2005. The National Provider Identifier (NPI) number assigned to this provider is 1346240231.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Myra Rose, MD has received a total of $258.76 in payments from pharmaceutical and medical device companies, with $64.13 received in 2024. These payments were reported across 12 transactions from 7 companies. The most common payment nature is "Food and Beverage" ($226.96).
As a Medicare-enrolled provider, Rose has provided services to 235 Medicare beneficiaries, totaling 402 services with total Medicare billing of $26,546. Data is available for 4 years (2020–2023), covering 10 distinct procedure/service records.
Practice Information
- Specialty Hematology & Oncology
- Other Specialties Internal Medicine
- Location Atlanta, GA
- Active Since 07/21/2005
- Last Updated 08/09/2021
- Taxonomy Code 207RH0003X
- Entity Type Individual
- NPI Number 1346240231
Products in Payments
- KEYTRUDA (Biological) $48.42
- PREVNAR - 13 (Biological) $42.76
- IBRANCE (Drug) $31.80
- FOUNDATIONONE (Device) $23.74
- Pomalyst (Drug) $18.49
- BLENREP (Biological) $16.34
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Hematology & Oncology Doctors in Atlanta
Dr. Jonathon Cohen, M.d, M.D
Hematology & Oncology — Payments: $330,523
Dr. Ajay Nooka, M.d., M.p.h.,F.a.c.p, M.D., M.P.H.,F.A.C.P
Hematology & Oncology — Payments: $256,358
Dr. Rodolfo Bordoni, Md, MD
Hematology & Oncology — Payments: $240,507
Dr. Mehmet Bilen, M.d, M.D
Hematology & Oncology — Payments: $134,196
Olatunji Alese, M.d, M.D
Hematology & Oncology — Payments: $131,083
Dr. Carlos Franco, Md, MD
Hematology & Oncology — Payments: $115,439